Clinical Trial Update: Phase I Study of Mitoxantrone Hydrochloride Liposome Injection [Phase 1]

View source ↗

Summary

A Phase I clinical trial evaluating mitoxantrone hydrochloride liposome injection for malignant lymphoma; the trial status is listed as unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Lymphoma

Drugs mentioned

• Mitoxantrone Hydrochloride Liposome Injection (mitoxantrone hydrochloride liposome)

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Malignant Lymphoma | Phase 1 | Status: UNKNOWN